Bipolar disorder pharma market share in 8 major markets for 2014 & 2024

Published by Statista Research Department, Mar 1, 2016
This statistic shows the comparison of the bipolar disorder market among 8 major pharmaceutical markets in 2014 and 2024. The sales share of Canada among these markets was 2.9 percent in 2014 and it is predicted to increase to 3.8 percent in 2024.

Share of bipolar disorder pharmaceutical sales among 8 major markets in 2014 and 2024

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

March 2016

Region

Worldwide

Survey time period

as of March 2016

Supplementary notes

8 major markets = US, France, Germany, Italy, Spain, UK, Japan, and Canada. Totals may not sum due to rounding.
* Forecast

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Boiron "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Boiron

Overview

5

Turnover

5

Financial data

7

Workforce

6

Shares

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in the UKGlobal pharmaceutical industryPharmaceutical industry in the U.S.AstraZenecaNational Health Service (NHS) UK
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu